Dx&Vx
Seoul
About Dx&Vx
Dx&Vx is an AI-based genome analysis platform that develops microbiome products for infants and young children.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $24.7M
- Funding stage: Seed
- Last round: Convertible Note (Oct 2022)
- Website: dxvx.com
- Phone: + 82 02 890 8700
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/dx-vx-97907 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.